Home » Health » HIV/AIDS: New drug against multi-resistant HI viruses

HIV/AIDS: New drug against multi-resistant HI viruses

HIV / AIDS

A new drug could significantly improve the chances of treatment for HIV/AIDS patients, in whom conventional drugs used in antiretroviral therapy are only poorly effective. The active ingredient lenacapavir, developed by the US pharmaceutical company Gilead, showed an effect in just over 80 percent of those treated in an efficacy study.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.